Fleisher Linda, Wen Kuang Yi, Miller Suzanne M, Diefenbach Michael, Stanton Annette L, Ropka Mary, Morra Marion, Raich Peter C
Associate Research Professor - Adjunct, Cancer Prevention and Control, Fox Chase Cancer Center, 333 Cottman Avenue, Philadelphia, PA 19111 USA. Senior Scientist, Children's Hospital of Philadelphia, USA, 3535 Market Street - Room 1177, Philadelphia, PA 19104 USA.
Assistant Professor, Cancer Prevention and Control, Fox Chase Cancer Center, 333 Cottman Avenue, Philadelphia, PA 19111 USA.
Internet Interv. 2015 Nov 1;2(4):392-398. doi: 10.1016/j.invent.2015.09.002.
Cancer patients and survivors are assuming active roles in decision-making and digital patient support tools are widely used to facilitate patient engagement. As part of Cancer Information Service Research Consortium's randomized controlled trials focused on the efficacy of eHealth interventions to promote informed treatment decision-making for newly diagnosed prostate and breast cancer patients, and post-treatment breast cancer, we conducted a rigorous process evaluation to examine the actual use of and perceived benefits of two complementary communication channels -- print and eHealth interventions.
The three Virtual Cancer Information Service (V-CIS) interventions were developed through a rigorous developmental process, guided by self-regulatory theory, informed decision-making frameworks, and health communications best practices. Control arm participants received NCI print materials; experimental arm participants received the additional V-CIS patient support tool. Actual usage data from the web-based V-CIS was also obtained and reported.
Print materials were highly used by all groups. About 60% of the experimental group reported using the V-CIS. Those who did use the V-CIS rated it highly on improvements in knowledge, patient-provider communication and decision-making.
The findings show that how patients actually use eHealth interventions either singularly or within the context of other communication channels is complex.
Integrating rigorous best practices and theoretical foundations is essential and multiple communication approaches should be considered to support patient preferences.
癌症患者及其幸存者在决策过程中发挥着积极作用,数字患者支持工具被广泛用于促进患者参与。作为癌症信息服务研究联盟随机对照试验的一部分,该试验聚焦于电子健康干预措施对新诊断的前列腺癌和乳腺癌患者以及乳腺癌治疗后患者促进明智治疗决策的疗效,我们进行了一项严格的过程评估,以考察两种互补沟通渠道——印刷品和电子健康干预措施的实际使用情况及感知益处。
三项虚拟癌症信息服务(V-CIS)干预措施是通过严格的开发过程制定的,以自我调节理论、明智决策框架和健康沟通最佳实践为指导。对照组参与者收到美国国立癌症研究所的印刷材料;实验组参与者收到额外的V-CIS患者支持工具。还获取并报告了基于网络的V-CIS的实际使用数据。
所有组对印刷材料的使用率都很高。约60%的实验组报告使用了V-CIS。那些确实使用了V-CIS的人对其在知识、医患沟通和决策方面的改善给予了高度评价。
研究结果表明,患者单独或在其他沟通渠道背景下实际使用电子健康干预措施的方式很复杂。
整合严格的最佳实践和理论基础至关重要,应考虑多种沟通方式以支持患者的偏好。